Health Care & Life Sciences » Pharmaceuticals | Cocrystal Pharma Inc.

Cocrystal Pharma Inc. | Key People and Executives

Gary L. Wilcox
Vice Chairman & Chief Executive Officer
Raymond F. Schinazi
Chairman
David S. Block
Independent Director
Steven D. Rubin
Independent Director
Jane H. Hsiao
Independent Director
Phillip Frost
Independent Director
Sam Lee
President
Gary L. Wilcox
Vice Chairman & Chief Executive Officer
James Joseph Martin
Chief Financial Officer
Roger David Kornberg
Chief Scientific Officer
Luz Pascual
Vice President-Clinical Development
Raymond F. Schinazi
Chairman
David S. Block
Independent Director
Steven D. Rubin
Independent Director
Jane H. Hsiao
Independent Director
Phillip Frost
Independent Director

About Cocrystal Pharma

View Profile
Address
19805 North Creek Parkway
Bothell Washington 98011
United States
Employees -
Website http://www.cocrystalpharma.com
Updated 07/08/2019
Cocrystal Pharma, Inc. is a clinical stage biotechnology company, which engages in discovering and developing novel antiviral therapeutics that target the replication machinery of hepatitis viruses, influenza viruses, and noroviruses. CC-31244 is a Phase 2a ready broad-spectrum novel non-nucleoside replication inhibitor of Hepatitis C. Phase 1b studies in Hepatitis C infected patients showed the largest reduction in viral load of any non-neoside inhibitor tested to date.